Pharmacogenomics of ABC transporters and its role in cancer chemotherapy

  • Sparreboom A
  • Danesi R
  • Ando Y
 et al. 
  • 3

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

ATP-binding cassette (ABC) genes play a role in the resistance of malignant cells to anticancer agents. The ABC gene products, including ABCB1 (P-glycoprotein), ABCC1 (MRP1), ABCC2 (MRP2, cMOAT), and ABCG2 (BCRP, MXR, ABCP) are also known to influence oral absorption and disposition of a wide variety of drugs. As a result, the expression levels of these proteins in humans have important consequences for an individual's susceptibility to certain drug-induced side effects, interactions, and treatment efficacy. Naturally occurring variants in ABC transporter genes have been identified that might affect the function and expression of the protein. This review focuses on recent advances in the pharmacogenomics of ABC transporters, and discusses potential implications of genetic variants for the chemotherapeutic treatment of cancer.

Author-supplied keywords

  • *Variation (Genetics)
  • ATP-Binding Cassette Transporters/classification/*
  • Drug Therapy/*trends
  • Gene Expression/drug effects/genetics
  • Genes, MDR/drug effects/genetics
  • Humans
  • Neoplasms/*drug therapy
  • Pharmacogenetics/*trends
  • Terminology as Topic

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • A Sparreboom

  • R Danesi

  • Y Ando

  • J Chan

  • W D Figg

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free